CD8A and COVID-19: Lymphopenia has often been described in severe COVID-19 patients, including a reduction in CD4+ and CD8+ T cells and NK cells (6, 7), and an upregulation of exhaustion markers on remaining CD8+ T cells and NK cells (8).